Genetic Determinants of UV-Susceptibility in Non-Melanoma Skin Cancer by Welsh, Marleen M. et al.
Genetic Determinants of UV-Susceptibility in Non-
Melanoma Skin Cancer
Marleen M. Welsh
1, Margaret R. Karagas
2,3, Jacquelyn K. Kuriger
4, Andres Houseman
6,7, Steven K.
Spencer
8, Ann E. Perry
9, Heather H. Nelson
4,5*
1Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America, 2Department
of Community and Family Medicine, Dartmouth Medical School, Lebanon, New Hampshire, United States of America, 3Norris Cotton Cancer Center, Dartmouth Medical
School, Lebanon, New Hampshire, United States of America, 4Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America,
5Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, United States of America, 6Department of Community Health,
Brown University, Providence, Rhode Island, United States of America, 7Center for Environmental Health and Technology, Brown University, Providence, Rhode Island,
United States of America, 8Department of Medicine, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States of America, 9Department of
Pathology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States of America
Abstract
A milieu of cytokines and signaling molecules are involved in the induction of UV-induced immune suppression and thus
the etiology of non-melanoma skin cancer (NMSC). Targeting the UV-induced immunosuppression pathway, and using a
large population based study of NMSC, we have investigated the risk associated with functional variants in 10 genes (IL10,
IL4, IL4R, TNF, TNFR2, HTR2A, HRH2, IL12B, PTGS2, and HAL). The most prominent single genetic effect was observed for IL10.
There was increasing risk for both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) with increasing number of
variant IL10 haplotypes (BCC: ptrend=0.0048; SCC: ptrend=0.031). Having two IL10 GC haplotypes was associated with
increased odds ratios of BCC and SCC (ORBCC=1.5, 95% CI 1.1–1.9; ORSCC=1.4, 95% CI 1.0–1.9), and these associations were
largely confined to women (ORBCC=2.2, 95% CI 1.4–3.4; SCC: ORSCC=1.8, 95% CI 1.1–3.0). To examine how combinations of
these variants contribute to risk of BCC and SCC, we used multifactor dimensionality reduction (MDR) and classification and
regression trees (CART). Results from both of these methods found that in men, a combination of skin type, burns, IL10, IL4R,
and possibly TNFR2 were important in both BCC and SCC. In women, skin type, burns, and IL10 were the most critical risk
factors in SCC, with risk of BCC involving these same factors plus genetic variants in HTR2A, IL12B and IL4R. These data
suggest differential genetic susceptibility to UV-induced immune suppression and skin cancer risk by gender.
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Introduction
While difficult to measure precisely due to lack of inclusion in
national cancer registries, the incidence of non-melanoma skin
cancers (NMSCs) in the US is estimated to have matched that of all
other cancers combined in 2005 [1] and has been increasing
dramatically over the last 25 years [2], with greater increases in
women than in men. While predisposing risk factors for NMSC
include pigmentation, gender, arsenic or ionizing radiation expo-
sure, and genetic disorders such as Xeroderma pigmentosum and
basal cell nevus syndrome [3], exposure to ultraviolet radiation
(UVR)isarguablythemostimportanttothedevelopmentofNMSC.
Separate from mutagenic effects, this type of UV is also
implicated in the etiology of cancer via immunosuppression. This
immunomodulation results in depletion of the Langerhans cells
from the epidermis, improper antigen presentation in the lymph
nodes, a shift towards Th2 responses, and development of tumor
antigen-specific T regulatory cells, resulting in blocked immune
surveillance and tumor outgrowth [4,5,6,7,8,9]. Studies using
antibody-mediated cytokine suppression and genetically engi-
neered mice have found a wealth of downstream mediators that
are critical in UV-induced immune responses.
Strains of inbred mice may be classified into distinct categories
of UV-susceptibility and UV-resistance following equal doses of
UVR, implicating a genetic component to susceptibility to UV-
induced immunosuppression [10]. In New Zealand black (NZB)
mice, a strain that exhibits deficiencies in maintaining self-
tolerance which lead to a murine form of human systemic lupus
erythematosis [11], there was a seven fold increase in sensitivity to
UVB in females compared to males, implicating possible gender
differences in this process. In both sexes, UV-susceptible mice
have higher incidence rates of skin cancer than UV-resistant mice
[12]. Preliminary data from two small studies in humans suggest a
similar association. An estimated 35–40% of humans may be
classified as having a UV-susceptible phenotype, as measured by a
contact hypersensitivity test [13,14]. One of these studies also
found that over 90% of skin cancer patients were of the UV-
susceptible phenotype [13], further linking cancer development,
genetic susceptibility, and UV immunosuppression.
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key mediators of UV-induced immunosuppression and risk of
NMSC, including investigation of both single and multiple gene
effects. Additionally, we investigated whether these effects varied
by gender, as past studies have indicated possible gender
differences in risk of NMSC from UV-induced immunosuppres-
sion.
Methods
Study Population
Newly diagnosed cases of histologically confirmed BCC and
SCC in New Hampshire were identified using an incident survey
established through the collaboration of dermatologists, dermato-
pathologists, and pathology laboratories throughout the state and
bordering regions from July 1, 1993 to June 30, 1995 (series 1) and
July 1, 1997 to March 30, 2000 (series 2) [2]. The study design of
The New Hampshire Health Study has been described previously
by Karagas et al. [2]. Briefly, eligibility criteria for cases were as
follows: 1) between 25 and 74 years of age, 2) had a listed
telephone number, and 3) spoke English. All eligible invasive SCC
cases and a ratio of approximately two to one BCC cases in series
1 and one to one ratio in series 2 were selected to take part in the
study. The BCC cases were randomly sampled in order to ensure
representativeness of age, sex, and anatomic site for all incident
BCCs within New Hampshire. Controls aged 25–64 years were
identified from the New Hampshire State Department of
Transportation files and those aged 65–74 years were obtained
from enrollment lists from the Center for Medicaid and Medicare
Services. Potential controls were frequency-matched on age and
gender to the combined distribution of case groups.
A personal interview was conducted with consenting cases and
controls, with about 80% of cases and 72% of controls agreeing to
participate. The interviews, usually conducted in the participant’s
home, covered demographic factors, pigmentation characteristics,
sun exposure and sensitivity, and other factors [2]. Blood draws
and/or buccal samples were obtained from cases and controls
from both phases of the study for DNA analysis. Approximately
85% of subjects consented to a providing a DNA sample; among
those that consented, 90% provided a blood-derived sample. All
study protocol and materials were approved by the Dartmouth
College Committee for the Protection of Human Subjects, and all
participants provided informed consent.
Genotyping
Functional polymorphisms in 10 immune-related genes were
genotyped (Table 1). DNA was extracted from peripheral blood
lymphocytes of consented cases and controls using Qiagen
Genomic DNA extraction kits (Valencia, CA). For quality
assurance purposes, 10% of blood and buccal samples were used
as integrated duplicates, to which researchers were blinded at the
time of genotyping. The genotypes of the embedded duplicates
were compared afterwards to that of the original samples to
calculate the genotyping error rate. All genotype error rates were
5% or less.
Genotyping for the histidase I439V SNP (rs7297245) was
performed by PCR-RFLP analysis. A 333 base pair fragment of
exon 16 of the HAL locus was amplified using primers as
previously described [26,27]. Genotyping of four SNPs
(rs1800629, rs3212227, rs2243250, rs1805010) was performed
on the Taqman allelic discrimination platform (Applied Biosys-
tems, Foster City, CA). Taqman primers, probes, and conditions
are available upon request. All other SNPs (rs6311, rs1800689,
rs1061622, rs1800896, rs1800871, rs1800872, rs689466,
rs1801275) were genotyping by the University of Minnesota
Biomedical Genomics Center using the Sequenom platform. Two
IL10 SNPs, rs1800871 and rs1800872, were in high linkage
disequilibrium (D’=0.99) in our population, and therefore
rs1800872 was not included in the analysis.
Logistic Regression
Adjusted odds ratios (ORs) and 95% confidence intervals for
each SNP were obtained using unconditional logistic regression
adjusting for age at diagnosis (continuous), gender, skin type and
lifetime number of severe sunburns. Self-reported sunburn history
was described as the lifetime number of painful sunburns that last
2 or more days. For all analyses, cutoffs were determined based on
the distribution in controls, creating groups of no (0), low (1–3),
and high ($4) burns. For stratified analysis, the no and low groups
were combined, as done in previous analysis [27]. The measure of
skin type, skin’s reaction to acute sun exposure, was also
trichotomized. Responses were grouped as tan, burn then tan,
or burn, if they responded that they burned and peeled or burned
and freckled.
Multifactor Dimensionality Reduction
Multifactor dimensionality reduction (MDR) is a nonparametric
analysis method in which multiple variables, or attributes, are
reduced into a single, binary attribute with ‘‘low risk’’ and ‘‘high
risk’’ categories. The specifics of the algorithm used have been
previously described [28]. Analysis was conducted for 1 through 5
factor attribute combinations. Ten-fold cross validation was used
to develop training and testing sets for each analysis. For those
models where the cross validation consistency (CVC) was not 10/
10, the true testing balance accuracy (TBA) of that combination
was recalculated using only those variables from the most accurate
model. This TBA and the original CVC were reported. To
determine statistical significance, a normal distribution of testing
balance accuracy values was derived by permutating the data 1000
times. As in logistic regression, all genotypes were binary except
IL10 and IL4R. Age was dichotomized as 60 and younger or over
60 years. All other variables were coded as described above.
Classification and Regression Trees
Classification and regression trees (CART) is a decision tree-
based analysis method that uses binary recursive partitioning to
create prediction rules for the outcome of interest. The details of
the algorithm used have been previously described [29,30]. All
variables were coded the same as in MDR analysis. A 10-fold cross
validation was used for model building, and the optimal tree was
chosen as the one with the highest ROC value. To compute the
prediction rate, a bootstrap aggregation method was applied to the
data, in which 500 trees were averaged to create a ‘‘committee of
experts’’ model to best explain the variability in the data.
Results
Evaluation of genetic variants was conducted in 2493
participants (852 controls, 931 BCC, 710 SCC). The frequency
distributions for age, sex, and other known risk factors for NMSC,
such as skin type and lifetime number of severe sunburns, are
shown in Table 2. The average age of participants was 61.3 years
(SD=10.6) for controls, 58.7 years (SD=11.1) for BCC, and 64.1
years (SD=8.7) for SCC. In all groups, there were more men than
women. BCC and SCC cases were more likely to have
experienced severe sunburns and were more likely to burn than
controls.
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individual effects of each SNP or haplotype in the pathway. While
controlling for age, sex, skin type, and lifetime number of
sunburns, IL10 GC haplotypes were associated with increased
risk of both BCC (Table 3) and SCC (Table 4). Having two GC
haploytypes, which is associated with higher IL10 expression than
the AT allele [20], was associated with increased ORs of BCC and
SCC (ORBCC=1.5, 95% CI 1.1–1.9; ORSCC=1.4, 95% CI 1.0–
1.9), although the association with SCC was of borderline
significance. There was evidence of a gene dosage effect, with
increasing ORs associated with number of GC haplotypes (BCC:
ptrend=0.0048; SCC: ptrend=0.031). After using the conservative
Bonferroni multiple comparisons correction for 10 independent
test (p,0.005), the trend in BCC remains significant, but the trend
is no longer significant in SCC. When the number of IL10 GC
haplotypes was treated as a continuous variable, there was a
significant 20% increase in risk of both BCC and SCC associated
with each additional GC haplotype (BCC: ORBCC=1.2, 95% CI
1.1–1.4; SCC: ORSCC=1.2, 95% CI 1.0–1.4), although again this
association was of borderline significance in SCC. As shown in a
previous study in this population, there was no significant
association between HAL genotype and BCC or SCC [27].
When stratified by gender, the IL10 association appeared to be
largely restricted to women for both histologies. For BCC and
SCC, women with 2 IL10 GC haplotypes had an OR of about 2
(ORBCC=2.2, 95%CI 1.4–3.4; ORSCC=1.8, 95% CI 1.1–3.0),
and these trends were significant (BCC: p=0.0005; SCC:
p=0.020). Again, after a Bonferroni correction for 20 indepen-
dent test (10 genes in men and 10 genes in women, p,0.0025), this
trend remains significant in BCC in women, but not SCC under
this more stringent requirement. Among men, the ORs were close
to one (BCC: OR=1.1, 95% CI 0.8–1.6; SCC: OR=1.2, 95% CI
0.8–1.7). As previously reported [27], HAL AG/GG was
associated with increased risk of SCC in women (Table 4,
Table 1. Functional polymorphisms in the UV-induced immunosuppression pathway.
Gene name (HUGO) Chromosome dbSNP ID Polymorphism Functionality
HAL 12q22-24.1 rs7297245 ARG, codon 439, exon 16 n/a
HTR2A 13q14-21 rs6311 TRC, 21438, promoter T.C expression [15]
HRH2 5q35.2 rs1800689 GRA, codon 181, exon 1 n/a
TNF 6p21.3 rs1800629 GRA, 2308, promoter A.G expression
[16,17]
TNFR2 1p36.2 rs1061622 TRG, codon 196, exon 7 G(R).T(M), NF-kB activation [18]
IL12B 5q31.1-33.1 rs3212227 ARC, +16974, 39UTR A.C IL-12 p70 secretion [19]
IL10 1q31-32 rs1800896 GRA, 21082, promoter GCC.ATA expression [20]
rs1800871 CRT, 2819, promoter
rs1800872 CRA, 2592, promoter
PTGS2 1q25.2-25.3 rs689466 GRA, 21195, promoter A.G expression [21]
IL4 5q31.1 rs2243250 CRT, 2590, promoter T.C expression [22]
IL4R 16p11.2-12. rs1805010 ARG, codon 75, exon 5 GG(VR).AA (IQ) sensitivity to IL-4 [23,24,25]
rs1801275 ARG, codon 576, exon 11
doi:10.1371/journal.pone.0020019.t001
Table 2. Population Demographics and Exposures.
Controls N=852 BCC N=931 SCC N=710
Age (SD) 61.3 (10.6) 58.7 (11.1) 64.1 (8.7)
Gender
Male 510 (59.9%) 521 (56.0%) 451 (63.5%)
Female 342 (40.1%) 410 (44.0%) 259 (36.5%)
Skin reaction to 1
st strong summer sun for one hour
Tan 162 (19.1%) 72 (7.7%) 72 (10.2%)
Burn then tan 426 (50.2%) 458 (49.3%) 321 (45.3%)
Burn 261 (30.7%) 400 (43.0%) 316 (44.6%)
missing 3 1 1
Lifetime severe sunburns
Low (0–3) 525 (65.2%) 459 (50.9%) 346 (50.7%)
High ($4) 280 (38.8%) 442 (61.2%) 336 (49.3%)
missing 47 30 28
doi:10.1371/journal.pone.0020019.t002
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BCC Controls N(%) Cases N (%) OR (95% CI)
a Men Women
HAL
AA 511 (61.2) 541 (59.8) Referent Referent Referent
AG 281 (33.7) 309 (34.1) 1.0 (0.8–1.3) 0.9 (0.7–1.2) 1.2 (0.8–1.6)
GG 43 (5.2) 55 (6.1) 1.2 (0.8–1.8) 1.5 (0.8–2.8) 0.9 (0.5–1.7)
AG/GG 324 (38.8) 364 (40.2) 1.1 (0.9–1.3) 1.0 (0.8–1.3) 1.1 (0.8–1.5)
HTR2A
CC 267 (33.1) 323 (36.3) Referent Referent Referent
CT 407 (50.5) 406 (45.7) 0.9 (0.7–1.1) 0.9 (0.7–1.2) 0.8 (0.6–1.2)
TT 132 (16.4) 160 (18.0) 1.0 (0.8–1.4) 0.9 (0.6–1.4) 1.1 (0.7–1.8)
HRH2
GG 714 (86.8) 791 (88.8) Referent Referent Referent
AG/AA 109 (13.2) 100 (11.2) 0.8 (0.6–1.1) 0.8 (0.5–1.1) 0.9 (0.6–1.4)
TNF
GG 571 (70.0) 612 (68.5) Referent Referent Referent
GA 223 (27.3) 265 (29.6) 1.1 (0.9–1.4) 1.1 (0.9–1.5) 1.1 (0.8–1.5)
AA 22 (2.7) 17 (1.9) 0.8 (0.4–1.5) 0.5 (0.2–1.4) 1.2 (0.4–3.1)
GA/AA 245 (30.0) 282 (31.5) 1.1 (0.9–1.3) 1.1 (0.8–1.4) 1.1 (0.8–1.5)
TNFR2
TT 503 (61.6) 558 (62.9) Referent Referent Referent
GT 268 (32.8) 283 (31.9) 1.0 (0.8–1.2) 0.9 (0.7–1.2) 1.1 (0.8–1.5)
GG 45 (5.5) 46 (5.2) 0.9 (0.6–1.5) 0.7 (0.4–1.2) 1.7 (0.8–3.9)
GT/GG 313 (38.4) 329 (37.1) 1.0 (0.8–1.2) 0.9 (0.7–1.1) 1.1 (0.8–1.5)
IL12B
AA 500 (65.5) 555 (65.7) Referent Referent Referent
AC 230 (30.1) 250 (29.6) 1.0 (0.8–1.2) 0.9 (0.6–1.2) 1.1 (0.8–1.5)
CC 33 (4.3) 40 (4.7) 1.0 (0.6–1.7) 1.3 (0.6–2.5) 0.8 (0.4–1.7)
AC/CC 263 (34.5) 290 (34.3) 1.0 (0.8–1.2) 0.9 (0.7–1.2) 1.1 (0.8–1.5)
IL10 G-C alleles
0 243 (29.6) 236 (26.2%) Referent Referent Referent
1 393 (47.8) 413 (45.8%) 1.1 (0.9–1.4) 1.0 (0.7–1.3) 1.2 (0.9–1.8)
2 186 (22.6) 252 (28.0%) 1.5 (1.1–1.9) 1.1 (0.8–1.6) 2.2 (1.4–3.4)
Test for trend p=0.0048 p=0.45 p=0.0005
PTGS2
GG 32 (3.8) 26 (2.9) Referent Referent Referent
AG 260 (31.1) 296 (32.7) 1.4 (0.8–2.4) 1.1 (0.6–2.1) 2.3 (0.8–6.6)
AA 544 (65.1) 582 (64.4) 1.2 (0.7–2.2) 1.1 (0.6–2.0) 1.9 (0.7–5.6)
GG/AG 292 (34.9) 322 (35.6) Referent Referent Referent
AA 544 (65.1) 582 (64.4) 1.2 (0.7–2.2) 1.1 (0.6–2.0) 1.9 (0.7–5.6)
IL4
CC 608 (75.9) 675 (75.7) Referent Referent Referent
CT 174 (21.7) 197 (22.1) 1.0 (0.8–1.3) 0.9 (0.7–1.3) 1.1 (0.7–1.6)
TT 19 (2.4) 20 (2.2) 0.9 (0.5–1.8) 0.7 (0.3–1.4) 2.7 (0.7–10.5)
CT/TT 193 (24.1) 217 (24.3) 1.0 (0.8–1.2) 0.9 (0.7–1.2) 1.1 (0.8–1.6)
IL4R var alleles
0 170 (23.1) 146 (17.9) Referent Referent Referent
1–2 481 (65.4) 576 (70.8) 1.4 (1.1–1.8) 1.4 (1.0–1.9) 1.5 (1.0–2.3)
3–4 84 (11.4) 92 (11.3) 1.3 (0.9–1.9) 1.3 (0.8–2.1) 1.3 (0.7–2.3)
Test for trend p=0.073 p=0.14 p=0.31
aORs adjusted for gender, age at tumor diagnosis, skin reaction to acute sun exposure, and lifetime number of severe sunburns.
doi:10.1371/journal.pone.0020019.t003
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SCC Controls N(%) Cases N (%) OR (95% CI)
a Men Women
a
HAL
AA 511 (61.2) 410 (58.9) Referent Referent Referent
AG 281 (33.7) 243 (34.9) 1.1 (0.9–1.3) 0.9 (0.7–1.2) 1.5 (1.0–2.2)
GG 43 (5.2) 43 (6.2) 1.3 (0.8–2.0) 1.3 (0.7–2.4) 1.3 (0.7–2.7)
AG/GG 324 (38.8) 286 (41.1) 1.1 (0.9–1.4) 0.9 (0.7–1.2) 1.5 (1.0–2.1)
HTR2A
CC 267 (33.1) 223 (33.4) Referent Referent Referent
CT 407 (50.5) 350 (52.4) 1.0 (0.8–1.3) 0.9 (0.7–1.2) 1.2 (0.8–1.8)
TT 132 (16.4) 95 (14.2) 0.8 (0.6–1.2) 0.8 (0.5–1.2) 0.9 (0.5–1.6)
HRH2
GG 714 (86.8) 587 (86.6) Referent Referent Referent
AG/AA 109 (13.2) 91 (13.4) 1.1 (0.8–1.4) 1.0 (0.6–1.4) 1.3 (0.8–2.2)
TNF
GG 571 (70.0) 476 (69.9) Referent Referent Referent
GA 223 (27.3) 188 (27.6) 1.0 (0.8–1.2) 1.1 (0.8–1.5) 0.8 (0.5–1.2)
AA 22 (2.7) 17 (2.5) 0.9 (0.5–1.8) 0.7 (0.3–1.7) 1.4 (0.5–4.1)
GA/AA 245 (30.0) 205 (30.1) 1.0 (0.8–1.2) 1.1 (0.8–1.4) 0.8 (0.6–1.2)
TNFR2
TT 503 (61.6) 396 (57.6) Referent Referent Referent
GT 268 (32.8) 259 (37.7) 1.2 (1.0–1.5) 1.3 (0.9–1.7) 1.1 (0.8–1.6)
GG 45 (5.5) 33 (4.8) 0.9 (0.6–1.5) 0.8 (0.4–1.4) 1.5 (0.6–3.7)
GT/GG 313 (38.4) 292 (42.4) 1.2 (0.9–1.4) 1.2 (0.9–1.5) 1.1 (0.8–1.6)
IL12B
AA 500 (65.5) 416 (65.2) Referent Referent Referent
AC 230 (30.1) 196 (30.7) 1.1 (0.9–1.4) 0.9 (0.7–1.3) 1.4 (1.0–2.1)
CC 33 (4.3) 26 (4.1) 0.9 (0.5–1.5) 0.9 (0.5–2.0) 0.8 (0.3–1.9)
AC/CC 263 (34.5) 222 (34.8) 1.1 (0.8–1.3) 0.9 (0.7–1.3) 1.3 (0.9–1.9)
IL10 G-C alleles
0 243 (29.6) 166 (24.1%) Referent Referent Referent
1 393 (47.8) 348(50.4%) 1.3 (1.0–1.7) 1.3 (0.9–1.8) 1.3 (0.9–2.0)
2 186 (22.6) 176 (25.5%) 1.4 (1.0–1.9) 1.2 (0.8–1.7) 1.8 (1.1–3.0)
Test for trend p=0.031 p=0.36 p=0.020
PTGS2
GG 32 (3.8) 29 (4.2) Referent Referent Referent
AG 260 (31.1) 209 (30.2) 0.9 (0.5–1.5) 1.0 (0.5–2.0) 0.5 (0.2–1.4)
AA 544 (65.1) 454 (65.6) 0.8 (0.5–1.4) 1.1 (0.5–2.1) 0.5 (0.2–1.2)
GG/AG 292 (34.9) 238 (34.2) Referent Referent Referent
AA 544 (65.1) 454 (65.6) 0.8 (0.5–1.4) 1.1 (0.6–2.1) 0.5 (0.2–1.2)
IL4
CC 608 (75.9) 512 (76.0) Referent Referent Referent
CT 174 (21.7) 150 (22.3) 1.1 (0.8–1.4) 1.1 (0.8–1.5) 1.1 (0.7–1.7)
TT 19 (2.4) 12 (1.8) 0.7 (0.3–1.4) 0.4 (0.1–1.0) 3.1 (0.7–13.9)
CT/TT 193 (24.1) 162 (24.0) 1.0 (0.8–1.3) 1.0 (0.7–1.3) 1.2 (0.8–1.8)
IL4R var alleles
0 170 (23.1) 131 (21.1) Referent Referent Referent
1–2 481 (65.4) 429 (69.0) 1.2 (0.9–1.5) 1.5 (1.1–2.1) 0.7 (0.4–1.1)
3–4 84 (11.4) 62 (10.0) 0.9 (0.6–1.4) 1.1 (0.7–1.9) 0.6 (0.3–1.3)
Test for trend p=0.98 p=0.28 p=0.11
aORs adjusted for gender, age at tumor diagnosis, skin reaction to acute sun exposure, and lifetime number of severe sunburn.
doi:10.1371/journal.pone.0020019.t004
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genes were associated with increased OR of SCC in men (Table 4,
OR=1.5, 95% CI 1.1–2.1) but not women.
MDR analysis for BCC found the most accurate one factor
model considers lifetime number of severe sunburns (testing
balance accuracy (TBA)=0.5729, cross validation consistency
(CVC)=10/10, p,0.001), but a 3 factor model including a
combination of skin type, burns, and IL4R genotype
(TBA=0.5684, CVC=9/10, p,0.002) and a 4 factor model
adding IL10 haplotypes (TBA=0.5627, CVC=8/10, p,0.005)
were also statistically significant. The best model of SCC included
skin type and sunburns (TBA=0.5794, CVC=9/10, p,0.001). A
three factor model including IL4R haplotypes (TBA=0.5718,
CVC=4/10, p,0.001) was also statistically significant but not
consistently computed as the best model. Of borderline statistical
significance was a four factor model including IL10 and IL4R
haplotypes (TBA=0.5434, CVC=5/10, p,0.054).
Similar results were found using CART. For BCC, combina-
tions of IL4R and IL10 and IL4 and burns was found among those
who tended to either burn or burn then tan and were older than
60 years (Figure 1). For SCC, a combination of IL10, TNFR2, and
IL4R were important genetic factors among those with a high
lifetime number of sunburns who tend to burn or burn then tan
(Figure 2).
When examining these factors in men only, the two analysis
methods identified skin type, burns, IL10, IL4R, and to a lesser
extent TNFR2 as contributing to risk of BCC. In men, the best
models in MDR consider lifetime number of severe sunburns
(TBA=0.5776, CVC=10/10, p,0.002) and a combination of
skin type, burns, and IL10 and IL4R haplotypes (TBA=0.5764,
CVC=10/10, p=0.002). Similarly, analysis using CART found
IL4R, IL10, and TNFR2 best predicted risk among those who
tended to burn or burn then tan and were older than 60 years.
In women only, both analysis methods found combinations of
skin type, burns, IL10, HTR2A, IL12B, and IL4R contributed to
risk of BCC. The best fit models for MDR included skin type and
IL10 (TBA=0.5908, CVC=10/10, p,0.008) and skin type,
burns and IL10 (TBA=0.5998, CVC=10/10, p,0.004). Skin
type, burns, IL10, HTR2A, IL12B, and IL4R were related to BCC
risk using CART.
As with BCC, the risk of SCC in men identified skin type, burns,
IL10, IL4R, and possibly TNFR2 as significant factors. In MDR,
the best model involved burns and IL10 and IL4R haplotypes
(TBA=0.5704, CVC=5/10, p,0.03). Using CART, two risk
groups were identified: one with burns, skin type, IL10, and
TNFR2, and a second with burns, age, skin type, and IL4R.
Among women, both methods found skin type, burns, and IL10
related to risk of SCC. By MDR, significant models included just
Figure 1. Classification and Regression Tree Analysis (CART) of BCC.
doi:10.1371/journal.pone.0020019.g001
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burns, and IL10 haplotypes (TBA=0.5861, CVC=8/10,
p,0.05). In CART, skin type, burns, IL10 and TNF best
explained the variation in the data.
Discussion
We have investigated the effects of multiple functional variants
in genes of the UV-induced immunosuppression pathway in non-
melanoma skin cancer etiology. We found a main effect for IL10
haplotypes in both BCC and SCC. Stratifying on gender suggested
this was primarily attributable to the strong association in women.
In men, skin type, burns, IL10, IL4R, and possibly TNFR2 were
associated with both BCC and SCC. In women, skin type, burns,
and IL10 were related to risk of SCC and BCC, and risk of BCC
additionally included HTR2A, IL12B and IL4R.
A prior study had examined the role of IL10 polymorphisms in
UV-induced immune suppression. In this phenotype study, a CA-
repeat polymorphism in the promoter region was not associated
with susceptibility to UV-induced immune suppression [31]. It is
possible that the CA repeat does not capture the reduced
expression phenotype associated with the 2 SNP haplotype in
our study. Additionally, a small population size (N=42) and the
large number of CA repeat alleles could have resulted in a false
negative finding. This study also examined the role of TNF -308
and found no association, consistent with our results.
Previous epidemiologic studies have found a similar link
between IL10 promoter polymorphisms and risk of NMSCs in
immunocompromised populations. Among renal transplant pa-
tients, a higher number of GC (or GCC) alleles was found in SCC
patients compared to unaffected patients [32], and secreted IL-10
levels were also higher in this group. This was not true for BCC. A
study in non-transplant patients examined the association of IL10 -
1082 and BCC and also found no association [33]. Therefore, our
association between BCC and IL10 appears to be a novel finding
that warrants replication in another population.
Other previous work focused on patients with epidermodyspla-
sia verruciformis (EV), a disease characterized by defects in cell-
mediated immunity that result in persistent infection with beta-
type human papillomavirus (b-HPV) and increased development
of non-melanoma skin cancer [34,35]. EV patients (n=19) were
more likely to have the low expressing (no GCC) alleles than
controls (n=25), and within EV patients, those that developed
malignancies (n=14) were also more likely to have low expressing
Figure 2. Classification and Regression Tree Analysis (CART) of SCC.
doi:10.1371/journal.pone.0020019.g002
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HPV-related NMSC that is unrelated to UV-induced immuno-
suppression.
A small study conducted in a Japanese population (32 BCC, 24
SCC, 50 controls) also found an inverse association between
number of GC(C) alleles and risk of in situ SCC (Bowen’s disease)
in non-transplant patients [36], but no association with BCC or
SCC. Bowen’s disease patients are excluded from our population;
therefore, we have no ability to asses this relationship. Previous
studies have shown much lower prevalence of these polymor-
phisms in Japanese populations [37,38,39] compared to Cauca-
sians. Thus, aside from the small study size ethnic variation may
account for differences in our results. Further, the control group
consisted partially of patients with fungal or bacterial infections,
which could potentially have been related to a pre-existing
immune problem.
MDR and CART analyses identified IL10 and IL4R haplotypes
as being related to both BCC and SCC. IL4 has been shown to
induce IL10 production in this pathway [40]. Further, IL4R is
necessary to up-regulate IL10, a key component in biasing
immune reactions towards the Th2 phenotype [41].
We have analyzed the role of gender differences in genetic
susceptibilityto UV-induced immunosuppression. Inadditiontothe
increased susceptibility to UV-induced immunosuppression seen in
the female NZB mice, evidence exists for a role of estrogen in
regulatingwiderimmunesignaling.Experimentalevidencesupports
the fact that estrogen promotes a Th-2 bias, similar to UVR. In
pregnancy, when circulating estrogen levels are high, the fetus
spontaneously releases Th-2 cytokines (i.e. IL-4 and IL-10), hence
biasing the mother’s immune system away from producing Th-1
type cytokines which are implicated in spontaneous abortions [42].
Similar to UVR, contraceptive level doses of b-estradiol result in
suppression of delayed-type hypersensitivity (DTH) reactions [43].
b-estradiol inhibits the recruitment of inflammatory cells types, such
as granulocytes, macrophages, and T cells, to sites of inflammation
[44]. Also, T cell activation does not occur, due to improper antigen
presentation from spleen antigen presenting cells (APCs) [43,45].
Considering women may be more primed for immune suppression
given the effects of b-estradiol, it is not surprising that our genetic
effects were stronger in women.
One advantage of a pathway-based analysis is the ability to
examine how combinations of genotypes contribute to disease risk.
Often this is done by examining all of the common variants in each
gene to guarantee complete coverage of all the variation in the
pathway. However, this approach is costly, and the large number of
data points and comparisons can increase the chances of type 2
errors. Instead, we have taken a phenotypic approach to pathway
analysis, using almost exclusively SNPs that have been reported as
functional in past studies (Table 1). While this does not guarantee full
coverage of the pathway variation, it has the advantage of improving
statistical power and improving interpretability, asthe genotypes have
an identified phenotype. However, it is important to note that
functionality of a SNP does not guarantee that it is the causal SNP, in
relation to the outcome of interest; the possibility of the causal SNP
being in linkage disequilibrium with the SNP examined still remains.
Major strengths of this study include the population-based nature
of the study and the large sample size included, yielding increased
generalizability and power to detect smaller genetic effects. Possible
limitations include recall bias and missing geneticinformation forall
variants in the population. Sun exposure risk factors of interest in
this study were determined by self-reported interview responses,
which are subject to recall bias. However, standardized interview
instruments like the one used in the NHHS tend to yield
reproducible results upon retest for many sun exposure variables
[46,47]. Additionally, there was no evidence of differential recall of
sunburns between cases and controls in either study. Finally, use of
sunburns as a categorical variable instead of a continuous variable
has been shown to improve reproducibility of recall [47].
While genotyping is not complete for any of the genes studied,
overall the rate of missing data is relatively small. For 8 of the 10
genes examined, 94% or greater of the 2,493 participants in this
study could be assigned a genotype or haplotye. IL12B and IL4R
had slightly lower overall genotyping rates, at 90.1% and 87.1%,
respectively. However, missing genetic information was not
associated with either outcome of interest for any of the genes
examined, so we do not believe that this is contributing to a
substantial bias in the study.
In this study, we have examined the role of functional
polymorphisms in the UV-induced immunosuppression pathway
and how they alter risk for NMSC. Like many other cancers, BCC
and SCC are both complex diseases where genetic predisposition
and environmental exposures, as well and their interactions,
contribute enormously to disease etiology. The combinations of
gene and environmental (sunburn) effects observed in this study
underline the importance of examining genetic variants as part of
the greater pathway to which they belong. While the highly
antigenic nature of NMSCs make them well-suited to examine the
role of genetic variants in the UV-induced immunosuppression
pathway, tumor surveillance plays a part in many types of cancers,
and thus the interactions found in this study may have applications
to a variety of solid tumor types.
Author Contributions
Conceived and designed the experiments: MWW MRK HHN. Performed
the experiments: MMW JKK. Analyzed the data: MMW AH HHN.
Contributed reagents/materials/analysis tools: MRK SKK AEP. Wrote
the paper: MWW MRK HHN.
References
1. ACS (2005) Cancer Facts and Figures 2005. Atlanta: American Cancer Society.
2. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA (1999) Increase
in incidence rates of basal cell and squamous cell skin cancer in New Hampshire,
USA. New Hampshire Skin Cancer Study Group. Int J Cancer 81: 555–559.
3. Karagas MR, Martin A. Weinstock, Heather H. Nelson (2006) Keratinocyte
Carcinomas (Basal and Squamous Cell Carcinomas of the Skin). In:
Schottenfeld DaJFF, ed. Cancer Epidemiology and Prevention, 3rd ed: Oxford
University Press, USA.
4. Morison WL, Bucana C, Kripke ML (1984) Systemic suppression of contact
hypersensitivity by UVB radiation is unrelated to the UVB-induced alterations
in the morphology and number of Langerhans cells. Immunology 52: 299–306.
5. Noonan FP, Bucana C, Sauder DN, De Fabo EC (1984) Mechanism of systemic
immune suppression by UV irradiation in vivo. II. The UV effects on number
and morphology of epidermal Langerhans cells and the UV-induced suppression
of contact hypersensitivity have different wavelength dependencies. J Immunol
132: 2408–2416.
6. Cooper KD, Oberhelman L, Hamilton TA, Baadsgaard O, Terhune M, et al.
(1992) UV exposure reduces immunization rates and promotes tolerance to
epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal
macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A
89: 8497–8501.
7. Saijo S, Kodari E, Kripke ML, Strickland FM (1996) UVB irradiation decreases
the magnitude of the Th1 response to hapten but does not increase the Th2
response. Photodermatol Photoimmunol Photomed 12: 145–153.
8. Ullrich SE, Kripke ML (1984) Mechanisms in the suppression of tumor rejection
produced in mice by repeated UV irradiation. J Immunol 133: 2786–2790.
9. Jessup JM, Hanna N, Palaszynski E, Kripke ML (1978) Mechanisms
of depressed reactivity to dinitrochlorobenzene and ultraviolet-induced
tumors during ultraviolet carcinogenesis in BALB/c mice. Cell Immunol 38:
105–115.
10. Noonan FP, Hoffman HA (1994) Susceptibility to immunosuppression by
ultraviolet B radiation in the mouse. Immunogenetics 39: 29–39.
Genes and UV-Susceptibility in Skin Cancer
PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e2001911. Borchers A, Ansari AA, Hsu T, Kono DH, Gershwin ME (2000) The
pathogenesis of autoimmunity in New Zealand mice. Semin Arthritis Rheum 29:
385–399.
12. Noonan FP, Muller HK, Fears TR, Kusewitt DF, Johnson TM, et al. (2003)
Mice with genetically determined high susceptibility to ultraviolet (UV)-induced
immunosuppression show enhanced UV carcinogenesis. J Invest Dermatol 121:
1175–1181.
13. Yoshikawa T, Rae V, Bruins-Slot W, Van den Berg JW, Taylor JR, et al. (1990)
Susceptibility to effects of UVB radiation on induction of contact hypersensitivity
as a risk factor for skin cancer in humans. J Invest Dermatol 95: 530–536.
14. Vermeer M, Schmieder GJ, Yoshikawa T, van den Berg JW, Metzman MS,
et al. (1991) Effects of ultraviolet B light on cutaneous immune responses of
humans with deeply pigmented skin. J Invest Dermatol 97: 729–734.
15. Myers RL, Airey DC, Manier DH, Shelton RC, Sanders-Bush E (2007)
Polymorphisms in the regulatory region of the human serotonin 5-HT2A
receptor gene (HTR2A) influence gene expression. Biol Psychiatry 61: 167–173.
16. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, et al.
(1996) Secretion of tumour necrosis factor alpha and lymphotoxin alpha in
relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for
inflammatory bowel disease. Scand J Immunol 43: 456–463.
17. Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, et al. (1996) Gene
polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha)
in multiple sclerosis and it’s influence on the regulation of TNF-alpha
production. Neurosci Lett 215: 75–78.
18. Morita C, Horiuchi T, Tsukamoto H, Hatta N, Kikuchi Y, et al. (2001)
Association of tumor necrosis factor receptor type II polymorphism 196R with
Systemic lupus erythematosus in the Japanese: molecular and functional
analysis. Arthritis Rheum 44: 2819–2827.
19. Seegers D, Zwiers A, Strober W, Pena AS, Bouma G (2002) A TaqI
polymorphism in the 39UTR of the IL-12 p40 gene correlates with increased
IL-12 secretion. Genes Immun 3: 419–423.
20. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, et al. (1997) An
investigation of polymorphism in the interleukin-10 gene promoter.
Eur J Immunogenet 24: 1–8.
21. Zhang X, Miao X, Tan W, Ning B, Liu Z, et al. (2005) Identification of
functional genetic variants in cyclooxygenase-2 and their association with risk of
esophageal cancer. Gastroenterology 129: 565–576.
22. Rosenwasser LJ, Klemm DJ, Dresback JK, Inamura H, Mascali JJ, et al. (1995)
Promoter polymorphisms in the chromosome 5 gene cluster in asthma and
atopy. Clin Exp Allergy 25 Suppl 2: 74–78. discussion 95-76.
23. Mitsuyasu H, Izuhara K, Mao XQ, Gao PS, Arinobu Y, et al. (1998) Ile50Val
variant of IL4R alpha upregulates IgE synthesis and associates with atopic
asthma. Nat Genet 19: 119–120.
24. Risma KA, Wang N, Andrews RP, Cunningham CM, Ericksen MB, et al. (2002)
V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced
IL-4 receptor function. J Immunol 169: 1604–1610.
25. Andrews RP, Burrell L, Rosa-Rosa L, Cunningham CM, Brzezinski JL, et al.
(2001) Analysis of the Ser786Pro interleukin-4 receptor alpha allelic variant in
allergic and nonallergic asthma and its functional consequences. Clin Immunol
100: 298–304.
26. Suchi M, Sano H, Mizuno H, Wada Y (1995) Molecular cloning and structural
characterization of the human histidase gene (HAL). Genomics 29: 98–104.
27. Welsh MM, Karagas MR, Applebaum KM, Spencer SK, Perry AE, et al. (2008)
A role for ultraviolet radiation immunosuppression in non-melanoma skin
cancer as evidenced by gene-environment interactions. Carcinogenesis.
28. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, et al. (2006) A flexible
computational framework for detecting, characterizing, and interpreting
statistical patterns of epistasis in genetic studies of human disease susceptibility.
J Theor Biol 241: 252–261.
29. Breiman L, Jerome Friedman, Richard Olsen, Charles Stone (1984) Classifica-
tion and Regression Trees. Pacific Grove: Wadsworth.
30. Steinberg DaPC (1997) CART–Classification and Regression Trees. San Diego,
CA: Salford Systems.
31. Allen MH, Skov L, Barber R, Trembath R, Simon J, et al. (1998) Ultraviolet B
induced suppression of induction of contact sensitivity in human skin is not
associated with tumour necrosis factor-alpha-308 or interleukin-10 genetic
polymorphisms. Br J Dermatol 139: 225–229.
32. Alamartine E, Berthoux P, Mariat C, Cambazard F, Berthoux F (2003)
Interleukin-10 promoter polymorphisms and susceptibility to skin squamous cell
carcinoma after renal transplantation. J Invest Dermatol 120: 99–103.
33. Wilkening S, Hemminki K, Rudnai P, Gurzau E, Koppova K, et al. (2006)
Case-control study in basal cell carcinoma of the skin: single nucleotide
polymorphisms in three interleukin promoters pre-analysed in pooled DNA.
Br J Dermatol 155: 1139–1144.
34. de Oliveira WR, Rady PL, Grady J, Hughes TK, Festa Neto C, et al. (2003)
Polymorphisms of the interleukin 10 gene promoter in patients from Brazil with
epidermodysplasia verruciformis. J Am Acad Dermatol 49: 639–643.
35. Majewski S, Jablonska S (1995) Epidermodysplasia verruciformis as a model of
human papillomavirus-induced genetic cancer of the skin. Arch Dermatol 131:
1312–1318.
36. Nagano T, Kunisada M, Yu X, Masaki T, Nishigori C (2008) Involvement of
interleukin-10 promoter polymorphisms in nonmelanoma skin cancers-a case
study in non-Caucasian skin cancer patients. Photochem Photobiol 84: 63–66.
37. Ide A, Kawasaki E, Abiru N, Sun F, Takahashi R, et al. (2002) Genetic
association between interleukin-10 gene promoter region polymorphisms and
type 1 diabetes age-at-onset. Hum Immunol 63: 690–695.
38. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, et al. (2002)
Influence of interleukin-10 gene promoter polymorphisms on disease progression
in patients chronically infected with hepatitis B virus. Am J Gastroenterol 97:
2086–2092.
39. Origuchi T, Kawasaki E, Ide A, Kamachi M, Tanaka F, et al. (2003) Correlation
between interleukin 10 gene promoter region polymorphisms and clinical
manifestations in Japanese patients with Sjogren’s syndrome. Ann Rheum Dis
62: 1117–1118.
40. Shreedhar V, Giese T, Sung VW, Ullrich SE (1998) A cytokine cascade
including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced
systemic immune suppression. J Immunol 160: 3783–3789.
41. Balic A, Harcus YM, Taylor MD, Brombacher F, Maizels RM (2006) IL-4R
signaling is required to induce IL-10 for the establishment of T(h)2 dominance.
Int Immunol 18: 1421–1431.
42. Wegmann TG, Lin H, Guilbert L, Mosmann TR (1993) Bidirectional cytokine
interactions in the maternal-fetal relationship: is successful pregnancy a TH2
phenomenon? Immunol Today 14: 353–356.
43. Salem ML, Matsuzaki G, Kishihara K, Madkour GA, Nomoto K (2000) beta-
estradiol suppresses T cell-mediated delayed-type hypersensitivity through
suppression of antigen-presenting cell function and Th1 induction. Int Arch
Allergy Immunol 121: 161–169.
44. Salem ML, Hossain MS, Nomoto K (2000) Mediation of the immunomodu-
latory effect of beta-estradiol on inflammatory responses by inhibition of
recruitment and activation of inflammatory cells and their gene expression of
TNF-alpha and IFN-gamma. Int Arch Allergy Immunol 121: 235–245.
45. Matsushima GK, Gilmore W, Casteel N, Frelinger JA, Stohlman SA (1989)
Evidence for a subpopulation of antigen-presenting cells specific for the
induction of the delayed-type hypersensitivity response. Cell Immunol 119:
171–181.
46. English DR, Armstrong BK, Kricker A (1998) Reproducibility of reported
measurements of sun exposure in a case-control study. Cancer Epidemiol
Biomarkers Prev 7: 857–863.
47. Rosso S, Minarro R, Schraub S, Tumino R, Franceschi S, et al. (2002)
Reproducibility of skin characteristic measurements and reported sun exposure
history. Int J Epidemiol 31: 439–446.
Genes and UV-Susceptibility in Skin Cancer
PLoS ONE | www.plosone.org 9 July 2011 | Volume 6 | Issue 7 | e20019